This is my protocol as well. My LDL-C is 17mg/dL and my ApoB is 37mg/dL. My CAC is ~40 or so. There’s nothing conclusive that suggests that one can reverse atherosclerosis, but there is a little data showing that it can occur in the presence of very low ApoB.
Atorvastatin and Rosuvastatin are fundamentally not interchangeable. They have similar efficacy. Adverse side effects tend to manifest differently in either. One is lipophilic and the other is hydrophilic.
“Long term safety profile” my ass. Yes, it’s true we have data that shows that long term use of atorvastatin won’t kill you. It will give you type 2 diabetes in high enough doses, though, and as the dose scales up, it becomes less efficacious and yields greater adverse side effects.
Goddamn that makes me mad. Here’s the dose response curve showing how various statins flat line in efficacy well before the maximally tolerated dose:
View attachment 306642
If, for example you happen to look at the adverse side effects for bempedoic acid, you’ll find “tendon rupture” among them. Scary stuff. Then if you dive into the research you will find that this only occurs in the presence of high dose statins and can’t be teased apart from statin use.
In any case, I have a hard time with the statin conspiracy theorists, but I understand that they exist because of this bullshit.
The person I trust most among every other in this department is Allan Sniderman. Probably one of the world’s leading experts in lipidology. He’s described ASCVD as a disease of the endothelium. It progresses incrementally and irreversibly through life. The presence of calcified plaque represents a later stage of this disease. Peter Attia did a 2hr podcast with him a couple years ago that’s worth listening to.
I also tend to follow Tom Dayspring, who is an adherent of Dr. Sniderman and has a lot of pragmatic advice. He’s definitely more vocal and active in social media. See “dr. Lipids” on Twitter.